Mucopolysaccharidosis Type 6 (MPS VI, Maroteaux-Lamy Syndrome) Latest Advances

Find the Latest Research About Mucopolysaccharidosis Type 6 (MPS VI, Maroteaux-Lamy Syndrome)

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 636 publications

RPE Abnormality Is a Potential Primary Cause for Retinal Degeneration in Mucopolysaccharidosis Type VI Patients and a Rat Model.

RPE Abnormality Is a Potential Primary Cause for Retinal Degeneration in Mucopolysaccharidosis Type VI Patients and a Rat Model.

Journal: Investigative ophthalmology & visual science
Published: May 18, 2026

A Rare Case of Mucopolysaccharidosis Presenting With Dysostosis Multiplex and Preserved Intelligence in a Seven-Year-Old Girl From Northeast India.

A Rare Case of Mucopolysaccharidosis Presenting With Dysostosis Multiplex and Preserved Intelligence in a Seven-Year-Old Girl From Northeast India.

Journal: Cureus
Published: May 14, 2026

Mucopolysaccharidosis Type VI Related Retinopathy.

Mucopolysaccharidosis Type VI Related Retinopathy.

Journal: Ophthalmology. Retina
Published: April 24, 2026

Chronic myeloid leukaemia in a child with mucopolysaccharidosis type VI: diagnostic and management challenges.

Chronic myeloid leukaemia in a child with mucopolysaccharidosis type VI: diagnostic and management challenges.

Journal: BMJ case reports
Published: February 25, 2026

Acute Airway Crisis in Mucopolysaccharidosis VI: Management Challenges.

Acute Airway Crisis in Mucopolysaccharidosis VI: Management Challenges.

Journal: Diagnostics (Basel, Switzerland)
Published: February 24, 2026

Choice of treatment strategy for corneal opacities in patients with mucopolysaccharidosis type VI

Choice of treatment strategy for corneal opacities in patients with mucopolysaccharidosis type VI

Journal: Vestnik oftalmologii
Published: December 23, 2025

Two-year follow-up of musculoskeletal outcomes and quality of life in patients with mucopolysaccharidosis type IV and VI.

Two-year follow-up of musculoskeletal outcomes and quality of life in patients with mucopolysaccharidosis type IV and VI.

Journal: Journal of pediatric endocrinology & metabolism : JPEM
Published: November 23, 2025

Mucopolysaccharidosis type VI in the Russian registry: Further insights and considerations.

Mucopolysaccharidosis type VI in the Russian registry: Further insights and considerations.

Journal: World journal of clinical pediatrics
Published: September 15, 2025

Mucopolysaccharidosis VI: Therapeutic strategies and perspectives.

Mucopolysaccharidosis VI: Therapeutic strategies and perspectives.

Journal: Molecular genetics and metabolism
Published: August 26, 2025

Anesthetic Management of Cesarean Section in a Patient With Mucopolysaccharidosis VI (MPS VI): A Case Report.

Anesthetic Management of Cesarean Section in a Patient With Mucopolysaccharidosis VI (MPS VI): A Case Report.

Journal: Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses
Published: August 24, 2025

Adeno-associated vector corneal gene therapy reverses corneal clouding in a feline model of mucopolysaccharidosis VI.

Adeno-associated vector corneal gene therapy reverses corneal clouding in a feline model of mucopolysaccharidosis VI.

Journal: PloS one
Published: July 25, 2025

Clinical and genetic characteristics of mucopolysaccharidosis type VI according to the Russian registry.

Clinical and genetic characteristics of mucopolysaccharidosis type VI according to the Russian registry.

Journal: World journal of clinical pediatrics
Published: May 29, 2025
Showing 1-12 of 636

Last Updated: 06/30/2026